biotech
FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on January 3, 2006
BlogPicture

Medimmune announced last week that the US FDA has approved its newly constructed influenza vaccine manufacturing facility in England, enabling them to to produce up to 15 million bulk doses per month, or approximately 90 million bulk doses per influenza manufacturing season, of its trivalent, intranasal influenza vaccine, FluMist (Influenza Virus Vaccine Live, Attenuated).

Additionally, the plant will be used to manufacture its investigational flu vaccine, CAIV-T, as well as year-round vaccine production in case of a flu pandemic.

Source: MedImmune

Permalink: FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility
Tags: flu  vaccine  biotech  influenza  manufacturing  influenza+vaccine  vaccine+manufacturing  manufacturing+fa 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/13162
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility:

  • Currently 7.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.50 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!